>sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2
MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPN
LFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTV
KTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHI
SESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESL
KKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVV
DTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEP
NDTDPLDSNVAHQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCD
QNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDC
ILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGL
EIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSY
KGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLT
SSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCEND
PKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLS
NLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYM
RVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNN
LALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVK
QHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLS
EHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSD
CKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKS
TFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDC
NKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISL
SSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENE
DNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQI
KEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAK
ESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTG
NQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFS
HQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNL
CRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTS
VSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYL
SNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAY
PQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIK
KVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKV
FADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFST
ASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLI
SQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQ
NVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQ
DKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSE
NYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILV
GEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKE
RQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTG
RPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKN
NSNQAAAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPR
ISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQ
LADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPK
EFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANI
SETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVG
SPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDV
IIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENT
TKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKK
QAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLL
TEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKF
LDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLI
AASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKL
MHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSV
STPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQP
PRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEK
QFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI
>tr|Q6PB43|Q6PB43_MOUSE Brca2 protein OS=Mus musculus GN=Brca2 PE=2 SV=1
MKTFSDVPVKTNVGEYYSKESENYFETEAVESAKAFMEDDELTDSEQTHAKCSLFTCPQN
ETLFNSRTRKRGGVTVDAVGQPPIKRSLLNEFDRIIESKGKSLTPSKSTPDGTVKDRSLF
THHMSLEPVTCGPFCSSKERQGAQRPHLTSPAQELLSKGHPWRHSALEKSPSSPIVSILP
AHDVSATRTERTRHSGKSTKVFVPPFKMKSQFHGDEHFNSKNVNLEGKNQKSTDGDREDG
NDSHVRQFNKDLMSSLQSARDLQDMRIKNKERRHLRLQPGSLYLTKSSTLPRISLQAAVG
DRAPSACSPKQLYIYGVSKECINVNSKNAEYFQFDIQDHFGKEDLCAGKGFQLADGGWLI
PSNDGKAGKEEFYRALCDTPGVDPKLISSIWVANHYRWIVWKLAAMEFAFPKEFANRCLN
PERVLLQLKYRYDVEIDNSRRSALKKILERDDTAAKTLVLCISDIISPSTKVSETSGGKT
SGEDANKVDTIELTDGWYAVRAQLDPPLMALVKSGKLTVGQKIITQGAELVGSPDACAPL
EAPDSLRLKISANSTRPARWHSRLGFFRDPRPFPLPLSSLFSDGGNVGCVDIIVQRVYPL
QWVEKTVSGLYIFRSEREEEKEALRFAEAQQKKLEALFTKVHTEFKDHEEDTTQRCVLSR
TLTRQQVHALQDGAELYAAVQYASDPDHLEACFSEEQLRALNNYRQMLNDKKQARIQSEF
RKALESAEKEEGLSRDVTTVWKLRVTSYKKKEKSALLSIWRPSSDLSSLLTEGKRYRIYH
LAVSKSKSKFERPSIQLTATKRTQYQQLPVSSETLLQVYQPRESLHFSRLSDPAFQPPCS
EVDVVGVVVSVVKPIGLAPLVYLSDECLNLLVVKFGIDLNEDIKPRVLIAASNLQCQPES
TSGVPTLFAGHFSIFSASPKEAYFQEKVNNLKHAIENIDTFYKEAEKKLIHVLEGDSPKW
STPNKDPTREPHAASTCCASDLLGSGGQFLRISPTGQQSYQSPLSHCTLKGKSMPLAHSA
QMAAKSWSGENEIDDPKTCRKRRALDFLSRLPLPSPVSPICTFVSPAAQKAFQPPRSCGT
KYATPIKKEPSSPRRRTPFQKTSGVSLPDCDSVADEELALLSTQALTPDSVGGNEQAFPG
DSTRNPQPAQRPDQQVGPRSRKESLRDCRGDSSEKLAVES
>tr|Q8UW79|Q8UW79_CHICK Tumor suppressor BRCA2 OS=Gallus gallus GN=brca2 PE=2 SV=1
MAYKSGKRPTFFEVFKAHCSDSDLGPISLDWFEELSSEAPPYEPKLLGEPEGPIGWFDQT
FKTPKAKSSTDSQLASTPLIFKEQNTMPPFSSPGKELDQKKMETSRENLLSPSMAGRKTD
QENQILASPHGICHNYTAASPAIVRNPCRTPQRSNIPGPYGSLFCTPKFLEIPTPKRISE
SLGAEVDPEMSWTSSLATPPTLGVTVIIARENDSISGAKQQDERAEIVLHNFLSEDDGYT
AKNDTSLLSIPETVKLNARDDIKDLESEVLDGLFGETNSFEDSFNLPAESSGILLSPRAL
DAIEKCEIKIDEAQEKSDVLSEQHMRRKSTISQEVKAANWTEKSCCVEVKDSIIQNTNED
IMDSKDNCLLGHEKELEYLRIAGNLQDNRTQKSSVNEKLVKDVLSSSSQWSQLNLSGLEC
NSSGMSICSSPQSDSCREKGLERESVLMTKDDAVETSLLNTSGLRNAQELSSASLSENGS
DTKISKNNPMSEITPVKPVCASPKLVKGYAHEDVSGMSFLNCSSFLIESTNVMEYSVVYN
STFSTHLKATSQSVVTDVLSHPLICSAASPDNCSDLHLRNSENTLRKSNFKSLNMLSRLR
KKSKRFIYTINNTLVYQEENVQKEVTSESPDNPVLTHLESDLHEFKDCQVATDGNQDCLL
SAERQSNIKENNLNTLTIKVDIMDNSSDNSVNNRLKQELSESGKNAREYQPATSFKCLKA
SHTESEDTTDCLNSGRISNIKHKVLTSAYLMARRHSRLFPEDCCLRKGKNDTYTVSNVNS
RAAVPWSPKGQPPQSSPSCSDCLIDMHHGTAFVTNSKFNNTLSHIKFGMNRVSSNSCNKI
LADKRRASDQLSVAECREIVAPLGINCLENNSTSLKQRGKEDVDENQETLSIKSSENPQA
AAWNNESIEVAEEFLDCIDNSLNEVVSEEDRQVAPVYFNTKPIESLEHKGKSSGDLNACS
SSLSFGGFQTASNKQIKFSESSIAKGKMLFKDIENEFFEASSMERVRNFSNRVQKENIFS
SDLESKTGSTSSGLQTRCMQYIPRKVDLCKNSPRNQLSVQEPNQSLTASQEAEIAELSNI
LEETGSQFEFTQFRKQSNMIQSHIQQFGATNVENASEAGEDTNFYSTLKSENHVINDEYC
SKSKNENECKMVEYEKEDTVVFHKNKREVTFTNLDRNESRISSHESCPVPLRDSFSNFVG
FTSAGGKKINISKAALTRSAELFKDLDDDNFLFKSSGTNTRCCNSDERVSSNWNFLRCQT
KEDEGGILCVPNIKSIGPISHHSEKKYAENISSPCEENTENWTEILSDNVDFSCTNGGYS
ASGMRNSPSSFKKPHQNCKNSDQFLNQGNSEVEGCLQEDTSYLICLGDNITSAEEHDLNV
SDEMENLSPNQKEDRKQEDEHLLLNRQAADTDAVSISDSSFRSSLRDLNVQCGERDTGVS
EKSSKQKTNSVSVEGEDSTYKNLFVSESEIKIGSNQRHQVPSEQEMDVDKNKVKGTYLTG
FCTASGKKITIADGFLAKAEEFFSENNVDLGKDDNDCFEDCLRKCNKSYVKDRDLCMDST
AHCDADVLNFKDKLIPQEPGDRLKQTIEESPIIQAVNHDSIKVGAFINVDEDCERNLAAP
CANKEAYVRPGRSEVESLPVHGNNSLSRTLLLEDRKRFAERDVEYSATKRDNPESKPDSS
LKCATSLHLTKVSSHLADNSVPGGIIQTVSAEDSCKSNQSFLLPRGSVPRSTSPYLNCGN
KEIDLKRLNEPCSNTDSFTNTVDNAHQEQSEFDLPEDETNLTCLQETSLNAESQKSDLKQ
VFSTAKGKAVSVSESALASIRQMFQTDCDASVKSEIETKSGTNQTAIAGSSSFSIHAGGP
GFATFLDTRKSEMNVAAPHFINGNGNLIENNHQGANMFADADSVPGFQMQCFEQKSKLLG
HFPVPDKQMEQSGPSGNLGFFSTASGKPVQLSEESLKKARQLFSEMEGSHSSGLQDAHLL
EDVEKSTNHGEVFPREMQLLLPRGKENASTDKISSPALGFSTASGKQVTISESAYQKAMA
ILKEADGFLSSELGVTNELCEIKESGQHAEYLTGKVISESKTEKSCSEELDLKSIHPEKM
KSLPSTHRVKITEYVPHSKRNSQSAPFKNSFEQEETRFFRKGELNLGIKTESESDLCSAT
SKAEINIFQTPKDYLKTEAVESAKAFMEDDLSDSGVQVKSAQSFGKMSDNFQNKPFGKRH
LDEKDSHGEPPIKRQLLLEFEKMKIPPKSVKPLKSTPDGIFKDRRKFMYHVPLKPVTCQP
LGTTKERQEVRNPTLTLPDQDLKGFKSIPAVFQHCALRQSSSGASGLFTPHKAVAKDSEE
TRSLCKSGKAVKTFVPPFKTKLTLSTGEQDGSKRCHSPIRNSVTEERELNQIPVEQNSAE
AQDHQSCILHAAVTDIENDNLITSNMMANLHCARDLQEMRIKKKYRQNISPQPGSLYVTK
TSARNRISLKTAVEEETPSFHSTEKLYTYGVSKHCIQVNSTNAESFQFLIEEFFSKEYLL
AGNGIHLADGGWLIPTDEGKAGKKEFYRALCDTPGVDPKLITEAWVYNHYRWIVWKLAAM
EVCFPHKFANRCLTPETVLLQLKYRYDLEIDKSKRSAIKKITERDDAAGKTLVLCVSKVL
SLNTAVSPSNSNNNTEGEKAAAIIEVTDGWYGIRALLDPPLKAFLHRRRLTVGQKIIVHG
AELIGSPNGCTPLEAPDSLMLKIAANSTRCARWYTKLGFHRDPRPFPLPLSSLYSEGGTV
GCIDVVVQRTYPIQWMEKTSAGSYVFRNSRAEEREAAKHAEDQQKKLEALFAKIQAEFEK
HEERNCRRAPRSRIVTRQQIHNLQDGAELYEAIQNAADPSYMEGYLSEDQLKALNAHKQL
MNDKKQTRIREEFKKAVESAEQEKHGFSKRDVSTVWKLFVVDYRKQEKHRGVILSIWRPL
LDVCSLLKEGSRYRICQLSTSQSKGRSDSTNVQLSATKKTRYLQLSVSQKMLQQIFFPRK
ALKFTSLLDPSYQPPCAEVDVVGVVISISRTGFSNMVYLSDESYNLVAIKIWADLRHFAI
EDIVVRCSFIAASNLQWQSEFRSEIPVLLAGDLSAFSASPKENHLQEKFNELRRMIENVD
SFCSDAESKLMNLLQRNCSLTPILPKRCGLECSSPSCNSGLYAEDRSSISSKIETKHPSP
LSASTPNTKLFPQGSAITPSSAVSSENHPRNSKKRKAVDFLSCIPAPPPLTPLCSIISPS
LKKAFQPPRRLGSQHSKLSKETNPNAGCVTPSRRLREAVQLPDNDLVADEELAMINTQAL
INTVPEEKKMDYVNEDGTRATNLSGDTRATNLSRDTRAPNLSGDLSSKNSSRSAKEANSS
LKSSSEGADALQKDTEEPEGSLSIRRVLQRRKSRKCY
>sp|O35923|BRCA2_RAT Breast cancer type 2 susceptibility protein homolog OS=Rattus norvegicus GN=Brca2 PE=1 SV=1
MTVEYKRRPTFWEIFKARCSTADLGPISLNWFEELFSEAPPYNTEHPEESEYKPQGHEPQ
LFKTPQRNPSYHQFASTPIMFKEQSQTLPLDQSPFKELGNVVANSKRKHHSKKKARKDPV
VDVASLPLKACPSESPCTPRCTQVAPQRRKPVVSGSLFYTPKLEETPKHISESLGVEVDP
DMSWTSSLATPPTLSSTVLIARDEEAHRNAFPADSPASLKSYFSNHNESLKKNDRFIPSV
SDSENKSQQEAFSQGLEKMLGDSSSKINRFRDCLRKPIPNVLEDGETAVDTSGEDSFSLC
FPKRRTRNLQKTRMGKMKKKIFSETRTDGLSEEARGQADDKNSFALEIEPRDSEPLDPSV
TNQKPLYSQSGDISSEAGQCSDSIWSQPDPSGLNGTQTRKIPLLHISFHKQSILEDFIDM
KKEGTGSITFPHISSLPEPEKMFSEETLVDKEHEGQHLESLEDSISGKQMVSGTSQTACL
SPSIRKSIVKMREPLEETLDTVFSDSMTSSAFTEELDASAGGLEIHTACSQREDSLCPSS
VDTGSWPTTLTDTSATVKNAGLITTLKNKRRKFIYSVSDDASHQGKKLQTQRQSELTNLS
APFEASAFEVPFPFTNVDSGIPDSSIKRSNLPNDPEEPSLSLTNSFVTAASKEISYIHAL
ISQDLNDKEAILSEEKPQPYTALEADFLSCLPERSCENDQKSPKVSDRKEKVLVSACRPS
GRLAAAVQLSSISFDSQENPLGSHNVTSTLKLTPSPKTPLSKPVVVSRGKMCKMPEKLQC
KSCKDNIELSKNIPLGVNEMCVLSENSETPELLPPLEYITEVSSSVKSQFNQNTKIAVVQ
KDQKDSTFISEVTVHMNSEELFPEKENNFAFQVTNESNKPNIGSTVEFQEEDLSHAKGHS
LKNSPMTVDRDLDDEQAGQVLITEDSDSLAVVHDCTKKSRNTIEQHQKGTADKDFKSNSS
LYLKSDGNNDYLDKWSEFLDPLMNHKLGGSFRTASNKEIKLSEDNVKKSKMFFKDIEEQY
PTSLDCIDTVSTLQLANKKRLSEPHTFDLKSGTTVSTQCHSQSSVSHEDTHTAPQMLSSK
QDFHSSHNLTPSQKAEITELSTILEESGSQFEFTQFKNPSHIAQNNTSAVLGNQMAVVRT
ASEEWKDVDLHLPLNPSSVGQIDHNKKFECLVGVKQSSSHLLEDTCNQNTSCFLPIKEME
FGGFCSALGTKLSVSNEALRKAMKLFSDIENISEEPSTKVGPRGFSSCAHHDSVASVFKI
KKQNTDKSFDEKSSKCQVTVQNNKEMTTCILVDENPENYVKNIKQDNNYTGSQRNAYKLE
NSDVSKSSTSGTVYINKGDSDLPFAAEKGNKYPESCTQYVREENAQIKESVSDLTCLEVM
KAEETCHMKSSDKEQLPSDKMEQNMKEFNISFQTASGKNIRVSKESLNKSVNILDQETED
LTVTSDSLNSKILCGINKDKMHISCHKKSINIKKVFEEHFPIGTVSQLPALQQYPEYEIE
SIKEPTLLSFHTASGKKVKIMQESLDKVKNLFDETQYVRKTTNFGHQESKPLKDREDYKE
RLTLAYEKIEVTASKCEEMQNFVSKQTEMLPQQNDHMYRQTENLTSNGSSPKVHGNIENK
IEKNPRICCICQSSYFVTEDSALACYTGDSRKTCVGESSLSKGKKWLREQSDKLGTRNTI
EIQCVKEHTEDFAGNALYEHSLVIIRTEIDTSHVSENQASTLFSDPNVCHSYLSHSSFCH
HDDMHNDSGYFLKDKIDSDVQPDMKNTEGNAIFPKISATKEIKLHPQTVNEECVQKLETN
ASPYANKNIAIDSAMLDLRNCKVGSPVFITTHSQETVRMKEIFTDNCSKIVEQNRESKPD
TCQTSCHKALDNSEDFICPSSSGDVCINSPMAIFYPQSEQILQHNQSVSGLKKAATPPVS
LETWDTCKSIRGSPQEVHPSRTYGFFSTASGKAVQVSDASLEKARQVFSEIDGDAKQLAS
MVSLEGNEKSHHSVKRESSVVHNTHGVLSLRKTLPGNVSSFVFSGFSTAGGKLVTVSESA
LHKVKGMLEEFDLIRTEHTLQHSPTPEDVSKIPPQPCLESRTPEYSVSSKLQKTYNDKSR
SPSNYKESGSSGNTQSLEVSPQLSQMERKQETQSVLGTKVSQRKTNILEKKQNLPQNIKI
ESNKMETFSDVSMKTNVGEYYSKEPENYFETEAVEIAKAFMEDDELTDSEQTHAKCSLFA
CPQNEALLNSRTRKRGGMAGVAVGQPPIKRSLLNEFDRIIESKGKSLTPSKSTPDGTIKD
RRLFTHHMSLEPVTCGPFCSSKERQETQSPHVTSPAQGLQSKEHPSRHSAVGKSSSNPTV
SALRSERTRHSVSDKSTKVFVPPFKVKSRFHRDEHFDSKNVNLEGKNQKSADGVSEDGND
SDFPQFNKDLMSSLQNARDLQDIRIKNKERHHLCPQPGSLYLTKSSTLPRISLQAAVGDS
VPSACSPKQLYMYGVSKACISVNSKNAEYFQFAIEDHFGKEALCAGKGFRLADGGWLIPS
DDGKAGKEEFYRALCDTPGVDPKLISSVWVSNHYRWIVWKLAAMEFAFPKEFANRCLNPE
RVLLQLKYRYDVEIDNSSRSALKKILERDDTAAKTLVLCVSDIISLSTNVSETSGSKASS
EDSNKVDTIELTDGWYAVKAQLDPPLLALVKSGRLTVGQKIITQGAELVGSPDACAPLEA
PDSLRLKISANSTRPARWHSKLGFFHDPRPFPLPLSSLFSDGGNVGCVDVIVQRVYPLQW
VEKTVSGSYIFRNEREEEKEALRFAEAQQKKLEALFTKVHTELKEHEEDIAQRRVLSRAL
TRQQVHALQDGAELYAAVQDASDPEHLETCFSEEQLRALNNYRQMLSDKKQARIQSEFRK
ALEAAEKEEGLSRDVSTVWKLRVTSYKKREKSALLSIWRPSSDLPSLLTEGQRYRIYHLS
VSKSKNKFEWPSIQLTATKRTQYQQLPVSSETLLQLYQPRELLPFSKLSDPAFQPPCSEV
DVVGVVVSVVKPIGLAPLVYLSDECLHLLVVKFGIDLNEDIKPRVLIAASNLQWRPESTS
RVPTLFAGNFSVFSASPKEAHFQERVTNMKHAIENIDTFYKEAEKKLIQVLKGDSPKWST
PNKDPTREPYPASTCSASDLASGGQLPRSSPTDQQSYRSPLSCCTPTGKSTPLAHSAWMA
AKSCSGENEIEDPKTCRKKRALDLLSRLPLPPPLSPVCTFVSPAAQKAFQPPRSCGTKYP
TPLKKEGPSSPWSRAPFQKASGVSLLDCDSVADEELALLSTQALVPHSVGGSEQVFPSDS
TRTEGPSASTEARPANRSKRESLRDCRDDSDGKLAAETVPDYS
>sp|Q9W157|BRCA2_DROME Breast cancer type 2 susceptibility protein homolog OS=Drosophila melanogaster GN=Brca2 PE=1 SV=3
MDQNGASGSHPNRLSQGRGAHARERGATVSAAANRSNIIDEMAKICEADRQTFAIARRTR
GHERLAVDNSDFVAVEDLILSYAEPTPEDQVEMIMSDFCSSPTYAEDEDEPSHESEPWFR
FRNKRIRTYSRKRDPKSHKAVQNEKRRGSSGLSVQRDLNTSFTSMACDFDASSQKIHEVL
LNLSQYFSATATASGPTPVPSQIDLPTEARQDSGDECFNAELENLRDDLLQSGFTFEASF
YENEHEQEGPGTMADTIYGDSMQSVPTTRLRLESGKRNVWSDADSTLKKADVEIAENKKL
LMGQTQAKNVDIEENTNFILEGIPLSEWLTPMELPEISKDVIKHIPDKKLKLEPSSQKEQ
KSSKDSNASKVRGASKQSCDINTKNEGTTILDQPNAAEQENLLNDGELLEEFLFNDWQPM
QCSNGPSTSKNAIQGPKENINSINLDDKEQPEKQTPNKSQTISSHQLNGIRKKSFKFIEV
SEEMKIKGEEFVDKVVSGLYHFSHKCNLRTEEYSDNHSQVMESTQCAEFKSAPSKPIEIL
DGKETYNAIAKVDVGEINGKFSPLNNDTIAEPEFCGFRTASNKAIPISEKMKIKTAEFMA
EFQSKETIQQNDYLVHQPNDKPTSVGLDTALKRSIESSEEMRSKASKLVVVDTTMREPHQ
PTLDPVCRDLNESQFFGFRTASNKAIEITEAMEKRGAMFLAQSKATDQLNGWQPSDFPDV
LPTSPNNEIHSINVENNKAVNTKTVSETEFFGFRTASNKGIVISENTKIKVAQFMSEFQA
ADASTDSNQPTVISEESRNIDAKFVDEAAAEDSANKPTFCNVQSLKNTSDIEHFKHDFFV
EHSAKEEHPLCSQPLVRTPRRSQEIHSSLSQLAGKSPLDQATKKSVIARRNLLSLKRKRK
IILSTETSTSCALPTMERFAPKPSSTSTPLADRDLNRSKDCTKNRQDAEDMSPICMQPKK
SRRLGLSRSRY
>tr|B7UAM6|B7UAM6_CANFA BRCA2 (Fragment) OS=Canis familiaris GN=BRCA2 PE=4 SV=1
SSIKKNCLQNDSEKPALSLTSSFGTILRKVSSNGASSPNNKIISQDPDYKEAKINKKKLE
SFITTETDCLSSLQEKHWEDDAKKQRVSDIKEKVLPTVSHPPVPHSEVEGSDIHFQSPES
FSFDCDNTSLLTPSSRDSPSSLVVMSRGKESYKISEKLKCKNHETGFELTKNIPMEKNQD
IHVLNADSKNAKLLSTEKHITVASSSVKVQFNQNANLTTIQKDQKETTLISKITVNPNSE
ELFPDDENNFVLKITNESNTPVLGNTKELHDSNLCCVRDSVPKNSTMVVCTDLDDKQTAK
VSIMKDCYSSSIDDLTERNRSTIKQQLKMTLDQDSKSDITSDIVRKSNGNSDYMDNWARL
SDPISNHSFENGFKTASNKEIKLSENNIRKSKMLFKDIEEHYPTNLACLEIVNTSSLESQ
KKPSKSHALDPQSINIISGFVQNSTYVSDSESGHTAPPTLSLKQDFDSNRNLTPSQKAEI
TELSTILEESGSQFEFTQFRKPSHIIQKNPFEMPENQLTILNSTSKEWKDDDLHLTTNAP
SISQVDSKKSEGIIGGKQKFACLSRTSCNRSASGYSTDKNEVEFRGFYSARGTKLNVGSE
ALQKAKKLFSDLENINEETSVEVDRSFSSSKYNDSVSMIQIEDCNDKNLNEKNNKCRLIL
QNNIEMTTDIFVEEYTESYRRNTENEGNQCTDAGRNTCNSESDGSDSSKNDTVYIHEEEN
GLPCIDQHNIDLKLFSQFMKEGNTQIKEGLSDLTCLEVMKAEETSHVTMSNKQQLTANTG
QNIKDFDTFYLSFQPASRKNIRVSKESLNKARSLLNQKWTEEELNNFSDSLNSELLPGID
IKKTDISNHEVIENTERKDKITKESDLIGTENILLILQQRPESKIKKIKESAVLGFHTAS
GKKIEITKESLDKVKNLFEEKEQDNSEITNFSHRGAKMSKDREECKDGRELACGTTEITT
TPEYEETHSSLEKKKLVSNEIAALRPRLLSDNLYKQTENLKISDHASQKVDVHENTEKET
AKKPTMYTNQSTYSAIENSPLTFYTGHGRKISVSEASLFEAKKWLREGEWDDQSERINAA
KVNCLKEYPDDYVENPSCGNSSNSAITENDKNHLSEKQGSTYLSNSTMSNSYSYHPGFCH
SSEVYNKSEYLSRSKIDNSGIEPVIKNIRERKNIGFSEIMSPGREADTDPQSVNEDICVE
KLATNSSCKNKNTAIKVAISDSNNFNTIQKLNSDSNNSVPAYSTVNSKRVFVAHQTKVTE
GFTDNCSMVTKQNTKSKSDTCHAEIVADYPKALDDSEAIFPNSLGAIECSPSHKVFADIQ
SEQTSQLNQSMSGLEKVSETPPCQINSKTSDRCELPRGKLPKSVSYTNACGIFSTASGKS
VQVSDAAIQKAREVFSKLEDSAKQLFPEVSLKDNEEHSEKFTNEENTVIYTSQNLLSSAF
SGFRTASGKQVPVSESALCKVKGMLEEFNLIRTESCLQHSSTSRQDVSKMPPPSCIGKRT
PEHSRNS
>sp|Q864S8|BRCA2_FELCA Breast cancer type 2 susceptibility protein homolog OS=Felis catus GN=BRCA2 PE=2 SV=2
MPIGCKERPTFFEIFRTRCNKADLGPISLNWFEELCLEAPPYNSEPTEESGYKISYEPNL
FKTPQRKPCHQLASTPIIFKEQGLIPPIYQQSPLKELGKDITNSKHRSCCTMKSKMDQTN
DVTSPPLNSCLSESPLLRSTHVTPQREKSVVCGSLFHTPKLTKGQTPKRISESLGAEVDP
DMSWSSSLATPPTLSSTVLIVRDEEASAAVFPNDTTAIFKSYFCNHDESLKKNDRFIPSG
PDSENKSQREAKSQGLGKMVGNSCDKVNSCKDPFGNSTLNVLEDGVRERVADVSEEDSFP
LCVPKCKTRNLQKIKTSKTRKNIFNETTDECKEAKKQMKENKHSFVSEMEANASDPLDSN
VTNQKPFGNGSDKISKEVVLSSASESCHLTLSGLNGTHMEKLPLLCISSCDQNNSEKDLI
TTEKECTNFIILEDSLPQISGVPKCTEKILNEEIVVNKIDEGQCLESHEDSILAVKQAVF
ETSLIASPLQGIRKSIFRIRESPEETFSAVFSNNITDPNFKEEHEASESVLEKHSICSQK
EDSLSTSSLDNGSWPATIKHTSVALKNSGLISTLKKKTKKFIYVVNDETSYQGLKTQKDQ
QSGLMNYSAQFEANVLEGPLTFANADSGLLHSSVKKTCLQNDSKEPILSLTNSFGTLLRK
VSNKGSSSPNNKIISQDLDYKEAKIKKEKLQSFISTETNCLSSLQEKHCEDDTKSQRVAD
RKEEILPAVSQPSVPYSEVEDSGIHFQTLKSFSSDPDKSSQLTPHPRDPPSNPVGLSRGR
ESYEVSETLKCKNHEAGFELTKTMENSQEIHVLNEHAKKAKLLSTEKYVTEASPSMKVPF
NQNAHLTIIQKDQKETTLISKITMNPNSEELFPDGDNFVFKITKERNVPVLGSIKELQDS
DLCCVKEPVLENSTMVVYTDMDDKQAAKVSITKGFDSSNIDDLTEKDRNSIKQQLRMTLD
QDSKSDITLDSDMKSNGNNDYMDNWARLSDPILNHNFGNGFRTASNKEIKLSEHNIKKSK
MLFKDIEERYPTNLACIEIVNTPLESQEKLSKPHILDPQSINTVSGCVQSSAYVSDSENR
HTTPPTLSLKRDFDSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSHLKQKNPCEM
PEKHLTISNTTPEEQKDGHLRLTINALSISQGDSSKKFEGIIGGKQKLACLSKTSCNKSA
SGHLTGKNEVEFRGFYSARGTKLNVCSEALQKAKKLFSDLENISEETSVEVDRSFSSSKC
NGSVSMFKKENCNNEKKLNEKNNKYRLILQNNIEMTTGIFVAEDTEGYKRNIENKANKYT
DASRNVYNFREADGSDSSKNDTVYIHKEENGLPYIDQHDIDLKLSSQFIKEGNTQIKEGL
SDLTCLEVVKAEETLHVNTSNKEHLTANTMGRITKDFDIFDVSFQTASGKNIRVSRASLN
KVTNLLDQKCTEEELNNFADSLNSELLSGIDINKADISHHGEMEILKKRQMKESDLTGTE
NKSLTLQQRPEYEIKKIKEPTILGFHTASGKRIEIAKESLDKVKNLFDEQEQDKSEMTNF
SHRGTKMSKGREECEGGLRLACKTIEITPASKEEEMQKPLEKNLVSNEIVVVPRLLSDNL
YKQTENLKIPNRASLKVKVHENTGKETAKKPTTCTNQSTYSATENSALSFYTGHGRKISV
SQSSILEVKKWLRGGELDDQPEKTVYNISEYLPKSKVDNSGIEPVVRNVGERENTSVSEI
MFTVREADTDPQSVNEDICVQRLVTNFSCKKENTAIKVTVSDSNNFDSTQKLNSDSNDAV
PVYTTASSERVLVAHETKVAEGFTENCSMAIKQTTKSKPGKIVAGYRKAPDDSEDTICPN
SLDGAECSSPSHKDFAETQSEQTPQLNQSISGFKKRSEIPPHQINLKTSDICKLSTGKRL
QSISYTNACGIFSTASGKCVQVSDAALQKARQVFSKVEDSAKQPFSKVSFKHNEDHSDKF
TREENTMIHTPQNLLSSAFSGFSTASGKQVPVSESALCKVKGILEEFDVMRTECGPQRSP
TSRQDVSKMPPPSCVENKTPKHSVNSKLEKAYNKEFKLSSNSKIENGSSENHSVQVSPYP
SQFKQDKQLIQGNKASLVENIHLLEKEQALPKNIKWKLETEAFPNLPLKTDTAIHSTDSK
DPENYFETETVEIAKAFMEDGELTDADLLSHARHFLPTCQHSEETLVSNSRRGKRRGVLV
SVGEPPIKRNLLNEFDRIIKNQEKSLKASKSTPDGIIKDRSLFMHHISLEPVTCGPFSTT
KKRQEIQNPNFTAPGQKFLSKSHFYEHLALEKSSSNVSISGQPFCTVPATRSEKRGHSIT
PSKPVKVFVPPFKTKSRFLQDEQHISKNTHVEENKQKPNNIDEHSSGDSKNNINNSEIHQ
LNKNNSSQAATMVFTKCEKEPLDLIASLQNARDIQDMRIREKRKQHIFPQPGSLFLAKTS
TVPRISLRVAVEGRVPSACSHKQLYMYGVSKHCVKINSKNAESFQFHTQDYFGKEVQWAK
EGIQLADGGWLIPSNDGKAGKEEFYRALCDTPGVDPNLISRIWVYNHYRWIIWKLAAMEF
AFPKEFANRCLSPERVLLQLKYRYDMEIDRSKRSAIKKIMERDDTAAKTLVLCISETISS
STDLSETSGSKTSGVGTKNVGIVELTDGWYAIKAQLDPPLLALVKKGRLTVGHKIIIHGA
ELAGSPDACTPLEAPESLILKISANSTRPACWYAKLGFFPDPRPFPLPLSSLFSDGGNVG
CVDVVIQRTYPIQWMEKTPSGLCIFRNEREEEREATKYAEAQQKKLEVLFNKIQAEFEKH
DENITKRCVPLRALTRQQVCALQDGAELYEAVKNAPDPASLEAYFSEEQIRALNNHRQML
NDKKQAQIQLEFRKAMESAEQGEQMLPRDVTTVWKMRIISYGKKEKDSVTLSIWRPSSDL
YSLLTEGKRYRIYHLATSQSKSKSERAHIQLTATKKTQYQQLPASDELLFQVYQPREPLY
FNKLLDPDFQPPCSEVDLIGFVVSVVKKIGFAPLVYLSDECHNLLAIKVWTDLNEDIVKP
HTLIAASNLQWRPESKSGIPTLFAGDFSRFSASPKEGHFQETFHKMKNTIENVETFCNDA
ENKLVHILNANSPKVSTPMKDYASEPHTIQTVLGLGNKLSMSSPNSEMNYQSPLSLCKPK
AKSVPTPGSAQMTSKSCYKGERELDDPKTCKKRKALDFLSRLPLPPPVSPICTFVSPAAQ
KAFQPPRSCGTKYETPIKKRELNSPQMTPLKFNDTSLVESDSIADEELALINTQALLSGL
AGEDQLMSLNDSPRTAPTSSKDYVRPKSYPTAPGIRDCENPQASTEGGEPDVQDTDTVKR
SSMRLQRRQQQT
